More than two years have now passed since the beginning of the COVID-19 pandemic—an epidemic that turned into the most serious healthcare crisis in modern history. According to Johns Hopkins University, 6.16 million people have lost their lives to the disease, and more than 493 million have been i
The recent healthcare crisis differed from earlier emergencies because it has spread to impact most industries and multiple financial systems around the world. As the COVID-19 pandemic continued for more than two years, countries around the world struggled to keep their healthcare systems working,
As the Omicron variant of the virus that caused the current pandemic spreads and mutates, people are left hoping this will be the end of the healthcare crisis. Unlike previous variants, Omicron seems to be more infectious but less severe . However, this doesn’t mean that scientists and doctors a
The COVID-19 pandemic has demonstrated that it is essential for biopharmaceutical organizations to act quickly and become flexible in production. Experts, such as the CHEManager International team, view four factors as unsolved challenges. They claim that the first challenge is COVID-19 related.
Almost two years have passed since the beginning of the COVID-19 pandemic that reshaped the world as we knew it. The virus responsible for the disease not only infected millions of people around the world, but also changed the way people live, work and spend their free time. Despite important
As the COVID-19 pandemic continues to spread across the globe, many people are worried that the current vaccination may not be sufficient to curb the spread of the virus. While the successful development of effective vaccines has been one of the greatest weapons against the pandemic, Delta and
